GATA6 and gastric cancer: Moreover, GATA6-AS1 has been found to be lowly expressed in GC, and upregulated GATA6-AS1 has been elucidated to suppress the progression of GC by downregulating FZD4 expression to inactivate the Wnt/β-catenin signaling pathway [13].